- Home
- ANVS vs CFND Comparison
ANVS vs CFND Comparison
Compare ANVS & CFND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANVS | CFND |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.3M | 36.5M |
| IPO Year | 2020 | 2025 |
Fundamental Metrics
Financial Performance| Metric | ANVS | CFND |
|---|---|---|
| Price | $4.18 | $5.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | ★ 4.0M | N/A |
| Earning Date | 11-12-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.11 | N/A |
| 52 Week High | $6.37 | N/A |
Technical Indicators
Market Signals| Indicator | ANVS | CFND |
|---|---|---|
| Relative Strength Index (RSI) | 56.39 | N/A |
| Support Level | $4.12 | N/A |
| Resistance Level | $4.64 | N/A |
| Average True Range (ATR) | 0.53 | 0.00 |
| MACD | -0.11 | 0.00 |
| Stochastic Oscillator | 23.89 | 0.00 |
Price Performance
Historical ComparisonAbout ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About CFND C1 Fund Inc.
C1 Fund Inc is a non-diversified, closed-end management investment company designed to give investors access to the private digital asset ecosystem. Its investment objective is to maximize its portfolio's total return. The fund targets a handpicked portfolio of the late-stage private companies driving the future of digital asset services and technology. It offers early access to the next generation of category-defining companies and aims to bridge the gap between public and private markets and give investors access to the private companies with the safeguards of a NYSE listed fund that is regulated and liquid.